Abu Dhabi performs world’s fifth bone marrow transplant for rare immune disorder

READY
Read by Emma, the Simply Abu Dhabi narrator.
A ten-year-old boy from Abu Dhabi has become only the fifth person worldwide to receive a bone marrow transplant for MAP3K14-related NIK deficiency, an exceptionally rare inherited immune disorder. The procedure, performed at Yas Clinic Khalifa City by the Abu Dhabi Bone Marrow Transplant Programme in collaboration with Abu Dhabi Stem Cells Centre, has restored his ability to fight infection after years of recurrent, serious illness that once seemed untreatable even in advanced centres abroad.
Salah Al Farawi was ten years old when his immune system began failing. For years, recurrent infections, cytomegalovirus, Epstein-Barr virus, cryptosporidium, moved through his body unchecked. Each one required individual treatment. Each one returned. His weight dropped. Growth stalled. Advanced medical centres abroad had no cure. Then, at Yas Clinic in Abu Dhabi, doctors identified what no other centre had successfully tried: a bone marrow transplant from his elder brother for MAP3K14-related NIK deficiency, an exceptionally rare inherited immune disorder. The procedure became only the fifth of its kind reported worldwide.
MAP3K14 gene mutation severely impairs immune system development and regulation. The standard response in such cases is to manage each infection as it appears, knowing the underlying deficiency cannot be addressed. But when Salah’s brother proved a fully matched donor, the Abu Dhabi Bone Marrow Transplant Programme saw an opportunity to move beyond management into restoration. Dr. Mansi Sachdev, Consultant in Paediatric Haematology and Bone Marrow Transplantation at Yas Clinic, oversaw the transplant at Khalifa City in collaboration with Abu Dhabi Stem Cells Centre. Following the procedure, Salah achieved full donor chimerism, the successful establishment of donor-derived blood and immune cells, and made a complete clinical recovery. No active infection remained. He was discharged home.
The significance extends beyond one patient. Abu Dhabi has historically imported expertise for rare inherited immune disorders, sending families abroad for treatment that advanced centres in Europe or North America could offer. This transplant marks a shift. Dr. Maysoon Al Karam, Chief Medical Officer at Yas Clinic, described the success as evidence of diagnostic and treatment capabilities now built locally, alongside specialised expertise in managing conditions once considered untreatable in the region. The Abu Dhabi Bone Marrow Transplant Programme has expanded from treating malignant diseases such as blood cancers to non-malignant conditions: inherited blood disorders, immune deficiencies, the rare mutations that families once travelled continents to address.
For the emirate’s healthcare system, the achievement signals clinical maturity. Abu Dhabi now possesses the technical expertise to treat conditions only a handful of centres worldwide have successfully managed. For families facing rare inherited immune disorders, it means access to specialist treatment without leaving home, and the beginning of a sustainable medical infrastructure in the Gulf region for diseases that once required a journey to Europe or North America. The Abu Dhabi Bone Marrow Transplant Programme continues to develop integrated models for complex conditions, positioning the emirate as a leader in precision medicine and rare disease management within the region.
What it means for Abu Dhabi
This transplant represents a significant milestone for the emirate’s healthcare system. Abu Dhabi now possesses the clinical and technical expertise to treat conditions that only a handful of centres worldwide have successfully managed, positioning the emirate as a destination for families with rare inherited immune disorders who might otherwise travel abroad for treatment. The success reinforces the emirate’s commitment to building self-sufficient medical capabilities across complex specialisations.
The achievement also underscores how advanced healthcare innovation is becoming embedded across Abu Dhabi’s medical institutions, enabling faster diagnosis and more sophisticated treatment of rare conditions. As the Abu Dhabi Bone Marrow Transplant Programme continues to develop integrated models for complex conditions, it strengthens the emirate’s position as a leader in precision medicine and rare disease management within the Gulf region.
Source: WAM